Estamos no ar no ! Saiba mais

P3 Health Partners

PIII

Valor de mercado US$ 16,2 mi

4,14 USD

0,00

0%

No fechamento Atualizado 16 de out. 16:00 EDT

1 dia

0%

5 dias

-17,03%

1 mês

-45,6%

3 meses

-62,74%

6 meses

65,6%

No acumulado do ano

18,29%

1 ano

-53,9%

5 anos

-99,16%

10 anos

-99,14%

Sobre: P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.

Funcionários: 320

Saúde Estabelecimentos de assistência médica

Notícias

Positivo

Neutro

Negativo

Sentimento 3 meses

Positivo 20%

Neutro 80%

Negativo 0%

P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced the appointment of Dr. Michael Millie as Chief Clinical Officer, effective October 12, 2026. Dr. Millie is a proven physician executive who most recently served as a Chief Medical Officer, overseeing clinical and value-based care programs. A surgeon by training, he holds an MD from the University of Nebraska.

P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer

P3 Health Partners Q2 Earnings Call Highlights

P3 Health Partners NASDAQ: PIII reported second-quarter adjusted EBITDA of $54 million and raised its full-year 2026 outlook, while noting that the quarterly result included $45 million of favorable payer settlements and prior-year development.

P3 Health Partners Q2 Earnings Call Highlights

P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript

P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript

P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript

P3 Health Partners Announces Second Quarter 2026 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2026. "Q2 demonstrates that the business is now executing according to our plan. We delivered $54 million of adjusted EBITDA, with the core business driving improved profitability quarter over quarter. Our results reflect the structural improvements.

P3 Health Partners Announces Second Quarter 2026 Results

P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2026 on Monday, August 10, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Second Quarter 2026 Earnings C.

P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call

24/7 Wall Street

Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners

President Trump's 12-word remark, “I don't think about Americans' financial situation, I don't think about anybody,” hit the wires, and the reaction showed up in the forgotten corners of the market, where micro-cap turnarounds priced like option contracts ripped higher on May 15 as traders rotated into beaten-down names with operational catalysts already in motion.

Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners

P3 Health Partners Inc. (PIII) Q1 2026 Earnings Call Transcript

P3 Health Partners Inc. (PIII) Q1 2026 Earnings Call Transcript

P3 Health Partners Inc. (PIII) Q1 2026 Earnings Call Transcript

P3 Health Partners Announces First Quarter 2026 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2026. "Q1 represents a meaningful turning point for the business. The $26 million of adjusted EBITDA we delivered this quarter reflects the cumulative impact of two years of deliberate work, including contract restructuring, network concentration, an.

P3 Health Partners Announces First Quarter 2026 Results

P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2026 on Thursday, May 14, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter 2026 Earnings Conf.

P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call

P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript

P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript

P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript

Ver ranking de notícias

Gráficos de preços implementados com Lightweight Charts™